RAKU CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.35 TWD | +1.14% |
|
-0.37% | -12.46% |
| Mar. 13 | Raku Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 31 | Raku Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| Sales 2022 | 440M 13.5M | Sales 2023 | 279M 8.58M | Capitalization | 545M 16.73M |
|---|---|---|---|---|---|
| Net income 2022 | -34M -1.04M | Net income 2023 | -109M -3.35M | EV / Sales 2022 | 3.27 x |
| Net Debt 2022 | 10.55M 324K | Net cash position 2023 | 91.22M 2.8M | EV / Sales 2023 | 1.62 x |
| P/E ratio 2022 |
-40.9
x | P/E ratio 2023 |
-5.01
x | Employees | 124 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 30.37% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.14% | ||
| 1 week | -0.37% | ||
| Current month | -1.11% | ||
| 1 month | -7.29% | ||
| 3 months | -9.49% | ||
| 6 months | +3.49% | ||
| Current year | -12.46% |
1 week
12.80
13.35
1 month
12.8014.35
Current year
12.8016.05
1 year
9.6331.05
3 years
9.6363.60
5 years
9.6363.60
10 years
9.6363.60
| Managers | Title | Age | Since |
|---|---|---|---|
Nei Wen Chang
CEO | Chief Executive Officer | 56 | 21-08-23 |
Wen Chien Chang
DFI | Director of Finance/CFO | - | 19-12-12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Cheng Jung Kao
BRD | Director/Board Member | - | 23-03-29 |
Cheng Tong Shih
BRD | Director/Board Member | - | 17-09-12 |
Shih Chang Liu
BRD | Director/Board Member | - | 12-06-15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 13.35 | +1.14% | 26,000 |
| 24-04-23 | 13.2 | +1.54% | 1,000 |
| 24-04-22 | 13 | -1.89% | 4,000 |
| 24-04-19 | 13.25 | +0.76% | 9,000 |
| 24-04-18 | 13.15 | -1.87% | 4,000 |
End-of-day quote Taipei Exchange, April 23, 2024
More quotes
Raku Co Ltd, formerly Kino Biotech Co., Ltd., is a Singapore-based company. The Company is an integrated bio-nutraceutical and cosmeceutical company. The Company is focused on product conceptualization, development, commercialization, brand marketing, sale and distribution of healthcare and beauty products. The Company provides healthcare and beauty products and services through brands, including Kinohimitsu, Activa and Xpertise. It has over two logistic and distribution centers in Malaysia and China. The Company provides products to China, Singapore, Malaysia, Vietnam, Thailand and Indonesia.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -12.46% | 14.6M | |
| +25.61% | 660B | |
| +22.92% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +12.32% | 219B | |
| -9.65% | 196B | |
| +6.48% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- 4154 Stock
